Cranberry Juice for Treatment of Urinary Tract Infections
NCT ID: NCT00093054
Last Updated: 2015-05-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
319 participants
INTERVENTIONAL
2004-11-30
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cranberry Juice for the Prevention of Recurrent Urinary Tract Infections
NCT00128128
Effects of Cranberry-Containing Products in Women With Recurrent Urinary Tract Infections (UTIs)
NCT00100061
Cranberry for the Prevention of Urinary Tract Infections
NCT02454309
Cranberry on Urinary Tract Infections
NCT01881165
Identification of the Cranberry Juice Compounds That Prevent Urinary Tract Infections
NCT00087828
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Cranberry juice
Cranberry juice
TID dosage for UTI treatment
2
Placebo juice
Placebo cranberry juice
TID placebo dosage to match active comparator
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cranberry juice
TID dosage for UTI treatment
Placebo cranberry juice
TID placebo dosage to match active comparator
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Antibiotics within 48 hours prior to study start
* Hospitalization for any reason within 2 weeks prior to study start
* Stones in urinary tract
* Plans to leave Ann Arbor within 6 months after study start
* Allergy to cranberry or cranberry compounds
* Pregnancy
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Center for Complementary and Integrative Health (NCCIH)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cibele T. Barbosa-Cesnik
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Michigan
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.